Royalty Pharma plc ($RPRX)
Coyne Terrance P. โ EVP & CFO
Shares
1,875
Price
$45.32
Total Value
$84,968.44
Nearby Earnings
Feb 10, 2026
EPS:Est: 1.33
Revenue:Est: $839.97M
Feb 11, 2026 ๐
EPS:1.46 (est: 1.33)+9.8%
Revenue:$874.00M (est: $859.00M)+1.8%
Transaction Details
| Insider | Coyne Terrance P. |
|---|---|
| Title | EVP & CFO |
| Transaction Date | Feb 23, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Class A Ordinary Shares |
| Direct/Indirect | Indirect |
| Nature of Ownership | TPC RP EPA1 LLC |
| Filing Date | Feb 25, 2026 |
| Shares Sold | 1,875 |
| Price per Share | $45.32 |
| Total Value | $84,968.44 |
| Shares Owned After | 47,636 |
| Derivative | No |
| Accession Number | 0001814876-26-000010 |
| Document | View SEC Filing |